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Abstract
Background: Breast cancer is the most common form of cancer among American women, accounting for 23% of all cancer
survivors nationally. Yet, the availability of adequate resources and tools for supporting breast cancer survivors has not kept up
with the rapid advancement in treatment options, resulting in unmet supportive care needs, particularly among low-income and
minority populations. This study explores an alternative means of delivering breast cancer survivorship care plans (SCPs), with
the aim of improving survivor morbidity, patient knowledge, and self-management of treatment-related symptoms, as well as
addressing inconsistencies in follow-up care visits.
Objective: The overall goal of this study is to improve the uptake of SCP recommendations via an educational intervention for
breast cancer survivors, to improve treatment-related morbidity, patient knowledge, self-management, and adherence to follow-up
visits. The specific aims of the study are to (1) evaluate the feasibility of the online SCP, and (2) assess the impact of the online
SCP on survivorship outcomes.
Methods: We will enroll 50 breast cancer survivors who have completed initial breast cancer treatment into a 2-armed,
randomized, waitlist-controlled pilot trial, and collect data at baseline and 6 months. For the first aim, we will use mixed methods,
including surveys and personal interviews among the intervention group, to determine the feasibility of providing an online,
interactive SCP (called ACESO) based on the survivors’ online user experience and their short-term adoption. For the secondary
aim, we will compare the 2 groups to assess the primary outcomes of survivor knowledge, self-efficacy for self-management,
perceived peer support, and adherence to SCP-recommended posttreatment follow-up visits to oncology and primary care; and
the secondary outcomes of treatment-related morbidity (body weight, fatigue, depression, anxiety, sexual function, distress, and
sleep quality). We assess these outcomes by using measurements from validated instruments with robust psychometric properties.
Results: We have developed and refined the online breast cancer survivorship plan, ACESO, with consultation from breast
cancer oncologists, nurses, and survivors. Approval for the study protocol has been obtained from the Institutional Review Board.
An advisory board has also been established to provide oversight and recommendations on the conduct of the study. The study
will be completed over a period of 2 years.
Conclusions: The results of this pilot study will inform the feasibility and design of a larger-scale pragmatic trial to evaluate
the impact of an online breast cancer SCP on treatment-related morbidity and self-efficacy for self-management.
International Registered Report Identifier (IRRID): PRR1-10.2196/23414
(JMIR Res Protoc 2020;9(12):e23414) doi: 10.2196/23414
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Breast cancer is the most common form of cancer among
American women, accounting for 23% of all survivors nationally
[1]. Owing to improvements in advanced screening and cancer
therapies, breast cancer patients are experiencing better
prognosis and higher survival rates than ever before. Yet, the
availability of adequate resources and tools for supporting breast
cancer survivors has not kept up with the rapid advancement in
treatment options, resulting in unmet supportive care needs
[2,3]. A survivorship care plan (SCP) [4], an integral element
of cancer survivorship planning, is a document provided to
patients completing initial cancer treatment that contains a
summary of treatments, a schedule of recommended follow-up
visits, and general information on treatment-related side effects.
However, for breast cancer survivors, SCPs in their current
form, as a static paper document, provide little-to-no benefit
over standard patient discharge procedures [5]. Furthermore,
despite the inclusion of SCPs in standard oncology practice, the
lack of evidence supporting improved health outcomes [6,7]
may be attributed to them being passive and generic in nature,
as well as their reliance on the patient to proactively check,
analyze, interpret, and retain the information they contain on a
routine basis [8-10]. Moreover, there is limited research studying
the role of eHealth literacy among survivors. Survivors are able
and willing to use online computer applications that generate
customized survivorship information [11]; however, prior
research shows that eHealth literacy is associated with access
to digital resources and level of education [12].
Recommendations by the National Cancer Institute (NCI), the
American Cancer Society (ACS), and the Institute of Medicine
(IOM) [13] have all emphasized the need to evaluate SCPs and
explore new delivery models. Therefore, examining alternative
means of delivering SCPs to improve both survivor and provider
outcomes warrants further investigation.
With consultation from experts, including survivors and
providers, we designed and developed a prototype of an
interactive and personalized online breast cancer survivorship
tool called ACESO (After-Cancer Education and Support
Operations). ACESO aims to enhance the continuity of care for
breast cancer survivors and improve their follow-up experiences,
especially as they deal with posttreatment challenges such as
comorbidities and side effects of treatment [14]. By transforming
the conventional, paper-based SCP into a personalized and
interactive survivorship resource, ACESO enables 2-way
interaction with the SCP by allowing patients to use the built-in
tool to track survivor symptoms and quality-of-life observations,
and in return, to receive timely and customized educational
alerts and individual reminders for follow-up visits. Moreover,
it provides an online platform for breast cancer survivors to
connect and interact with peers on survivorship topics and
develop a peer support network.
This study’s overall goal is to improve the uptake of SCP
recommendations via an educational intervention for breast
cancer survivors, with the aim of improving treatment-related
morbidity, patient knowledge, self-management, and adherence
to follow-up visits. The specific aims are, firstly, to assess
ACESO’s feasibility. Based on results from our preliminary
study [14], breast cancer survivors reported high usability and
perceived usefulness of ACESO. We will use mixed methods,
including surveys and personal interviews, to determine the
feasibility of providing an online, interactive SCP (ACESO)
based on the online user experiences and short-term adoption
of 25 participants. Secondly, we aim to evaluate the extent of
ACESO’s impact on breast cancer survivorship. We will enroll
50 breast cancer survivors who have completed initial breast
cancer treatment (radiation, chemotherapy, or surgery) into a
2-armed, randomized, waitlist-controlled pilot trial, with SCP
only as the control, and ACESO with SCP as the intervention.
The primary outcomes will be (1) survivor knowledge, (2)
self-efficacy for self-management, (3) perceived peer support,
and (4) adherence to SCP-recommended posttreatment follow-up
visits to oncology and primary care; the secondary outcome
will be treatment-related morbidity (body weight, fatigue,
depression, anxiety, sexual function, distress, and sleep quality).
Outcome measurements will be collected at baseline and at 6
months. We hypothesize that ACESO users will show greater
improvement across the primary and secondary outcomes than
the waitlist control group.
Methods
Study Design
We will utilize a mixed-methods approach to evaluate the
survivor experience and the impact of an interactive SCP tool
in this 2-armed, randomized, waitlist-controlled pilot trial using
a pretest and posttest design. Study design and reporting will
be in accordance with the Consolidated Standards of Reporting
Trials (CONSORT) eHealth checklist. We will randomly
allocate breast cancer survivors to either the ACESO
(intervention) or the waitlist control group. We will measure
study outcomes at baseline and at 6 months.
Sample Size
We will seek to enroll 50 breast cancer survivors into the study;
25 will be randomly assigned to the waitlist control group and
25 will be randomly assigned to the intervention (ACESO)
group. When a paired t test with a significance level of 0.05 is
used, our sample size is estimated to achieve over 85% power
in detecting an increment of 5.97 (9.70%) in self-efficacy for
self-management scores in the intervention group. Our
calculations are based on prior studies evaluating the impact of
online interventions on self-efficacy for self-management among
cancer patients [15,16]. Allowing for a 10% attrition rate, we
estimate that we will obtain complete data on 22 participants
in each group.
Recruitment and Setting
We will recruit 50 patients completing primary invasive breast
cancer treatment (radiation, chemotherapy, or surgery) from a
breast cancer surgical oncology clinic located in the
Southeastern United States to participate in this proposed study.
The clinic served approximately 1160 patients in 2019;
therefore, it will provide access to a large and diverse pool of
prospective participants for successful recruitment. To be
included, patients must (1) be diagnosed with breast cancer at
the age of 21 years or older; (2) be within 3 months of
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completing initial treatment for localized breast cancer (ie, total
or partial mastectomy, radiotherapy, or chemotherapy; patients
still undergoing hormone therapy will be eligible to participate);
(3) not have a history of any other form of cancer; and (4) have
the ability to read and write at eighth-grade level English. There
are no inclusion or exclusion criteria that are based on gender
or race; however, we anticipate the recruitment of mostly (n=50)
female breast cancer survivors. Initial contact takes place at the
clinic, where the patient population is predominantly female
and reflective of the racial and ethnic diversity of the county
where the clinic is located; this is demonstrated in our expected
enrollment table (Multimedia Appendix 1). Certain groups,
including Native Hawaiian and American Indian groups, account
for less than 1% of the population (per 2018 census data) of the
county where the clinic is located; as such, every effort will be
made to include participants from these groups, but given the
relatively smaller sample size (n=50) of this feasibility pilot
study, it is not deemed likely.
Study Procedure
Our anticipated study timeline is presented in Multimedia
Appendix 2. An informational flyer containing a description
and contact information for the research study will be enclosed
with the SCP provided to each patient at the clinic. The study
coordinator will meet with interested patients after the
completion of their SCP clinic visit. Prospective participants
will be screened to verify that they meet the inclusion criteria.
Eligible patients will be provided with detailed study
information, and informed consent will be obtained. Enrolled
participants will immediately complete an online,
self-administered survey using a provided web-enabled device
to collect baseline measurements before randomization. To
ensure accuracy, the nurse-trained study coordinator will assist
all participants in completing the final section of the survey
using their conventional SCP to enter details regarding their
breast cancer diagnosis, treatment history, and schedule of
SCP-recommended follow-up visits. All participants will be
emailed a link to complete the online postintervention survey
6 months from the enrollment date. All surveys will be
administered using REDCap (Research Electronic Data Capture)
[17]. The study protocol has been approved by the Institutional
Review Board and will be registered at clinicaltrials.gov prior
to commencing the study activities.
Randomization
Upon obtaining baseline measures, the biostatistician will use
SAS software (version 9.4; SAS Institute) to perform a stratified
blocked randomization [18] with randomly permuted block
sizes. Survivors will be randomly allocated to either the waitlist
control group or the intervention (ACESO) group, with a 1:1
ratio (N=50). Stratification will be based on breast cancer
diagnosis (ie, breast cancer staging and hormone receptor status)
and type of breast cancer treatment (radiation, chemotherapy,
surgery, and hormone therapy) because they are both associated
with the occurrence and severity of treatment-related symptoms
and overall quality of life [19-24]. The study navigator will
subsequently implement the group allocations and contact
patients via an email and follow-up phone call within 3 business
days to explain group assignments and assist with the setting
up of participant user accounts, usernames, and passwords (for
the intervention group). To protect participant confidentiality
and privacy, we will encrypt all usernames, passwords, and
email addresses used on the website. Participants will be advised
to change their assigned password to their own chosen password
during the first login. The study navigator who is aware of group
assignments will be sequestered from other research assistants
and will not administer study surveys or interviews.
Waitlist Control
The proposed study evaluates an education-based intervention
on psychosocial outcomes and will employ a waitlist control
condition [25]. Participants assigned to this group will continue
to receive usual care and be notified that they are on a waiting
list to receive the intervention. The oncology clinic currently
provides SCPs to all its patients after treatment completion as
part of usual care. However, the paper-based document provides
generic information that is not customized for individual
patients. Moreover, it does not provide self-tracking of
symptoms and quality-of-life indicators affecting breast cancer
survivors, and lacks any resources that provide peer support to
survivors. After the completion of posttest measures, all
participants in the waitlist control group will be provided access
and invited to use ACESO.
Intervention
Participants in this group will also receive the conventional SCP
as part of usual care, in addition to access to the ACESO
website. After randomization, a nurse-trained study navigator
will assist patients with creating and setting up their user
accounts, as well as entering their breast cancer diagnosis,
treatments, and recommended follow-up schedule data as
indicated in their conventional SCP into ACESO. Participants
in the intervention group will receive basic training on how to
use ACESO and will be familiarized with its features and
functions. Participants in this group will use ACESO for (1)
logging observed survivor symptoms; (2) built-in self-tracking
and charting of treatment-related morbidity (weight, fatigue,
depression, anxiety, sexual function, distress, and sleep quality;
Table 1 [26-38]); (3) personalized, risk-adapted, and customized
educational alerts and tips for symptom management, based on
treatment history and self-reported symptoms; (4) email
reminders for scheduling SCP-recommended follow-up visits
a week prior to a visit due date; (5) monthly reminders and
instructions to perform breast self-examinations; (6) an online
discussion forum for communicating with other participants in
this group about survivorship related topics; and (7) access to
a list of evidence-based survivorship resources from NCI and
ACS.
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Study groupStudy outcomes and measurement instruments
Aim 1: Assess ACESO’s feasibility
.88PatientYesNoInterventionPatient experience of ACESO: online user experience scale
N/AaPatientYesNoInterventionPosttest participants’ experience interview
N/AAutomated track-
ing on website
YesNoInterventionAdoption: login frequency, average session duration, days of use, visits
by page, discussion forum participation (number of original posts; reply
posts)
Aim 2: Evaluate the extent of ACESO’s impact on breast cancer survivorship
Primary outcome: treatment-related morbidity
.87PatientYesYesControl &
intervention









Adherence to posttreatment oncologist and primary-care physician
visits
Secondary Outcome: Treatment-related morbidity
.96PatientYesYesControl &
intervention









Sexual function (Female Sexual Function Index)
.81PatientYesYesControl &
intervention
Distress (NCCNe Distress Thermometer)
.83PatientYesYesControl &
intervention
Sleep quality (Pittsburgh Sleep Quality Index)
N/APatientYesYesControl &
intervention




Age, race/ethnicity, education, income, etc.
N/APatientNoYesControl &
intervention
Breast cancer diagnosis (staging and hormone receptor status)
N/APatientNoYesControl &
intervention
Type of breast cancer treatment
aN/A: not applicable.
bWiSDOM-B: Wisconsin Survey of Cancer Diagnosis and Management in Breast Cancer.
cCES-D-10: 10-item Center for Epidemiological Studies Depression Scale.
dGAD-7: 7-item Generalized Anxiety Disorder scale.
eNCCN: National Comprehensive Cancer Network.
All participants will be informed at enrollment that the tool is
to support survivor education and for self-management, and
that it is not intended to replace the advice of a clinician. The
content and presentation of the educational alert messages have
been curated by a team of experts, comprising a breast cancer
oncologist, a breast cancer nurse practitioner, and 3 breast cancer
survivors. All alert messages will include text to consult the
primary-care physician if symptoms do not improve or worsen.
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The online discussion forum will be moderated by a nurse to
prevent the sharing of inaccurate and potentially harmful health
information, unauthorized use (such as spamming or
advertising), hateful conduct, or harassment. However, no
research staff will actively participate in conversations on the
discussion forum to let conversations among survivors develop
organically, and to mitigate the potential of the Hawthorne effect
[39]. Participants will be exposed to the intervention for 6
months for the measurement of postintervention outcomes;
however, they may continue to use the resource even beyond
the study period if they find it beneficial and wish to continue
using it.
Outcome Measures
For the first aim, we will employ a mixed-methods approach
[40] to evaluate ACESO’s feasibility based on the survivors’
online user experience and short-term adoption (25/50).
Quantitative data on the participants’ online user experience
based on their use and perception of ACESO will be collected
using a structured survey [41,42]. We will measure online user
experience after 6 months of use to measure user perception of
ACESO based on 4 dimensions: pragmatic (or utilitarian
experience), hedonic (or affective experience), sociability, and
usability experience [41,42]. It has been shown that sustained
use and adoption for any technological environment depend on
whether participants rate these experiences satisfactory or above
[41-43]. To measure adoption, we will use automated tracking
of logins to ACESO. In addition, we will also track the average
time spent for each login session, the number of days of login,
the visits for each page of the web application, and discussion
group participation (number of original posts and replies to
other posts). Qualitative data will be collected by inviting all
ACESO users to share their experiences and perceptions of the
intervention via a postintervention, in-depth interview conducted
on the phone. We will use open-ended questions in combination
with probing to gather participant experiences (Multimedia
Appendix 3). To ensure participant confidentiality, the research
assistants will conduct all interviews in a private, closed room.
All interviews will be audiotaped and subsequently transcribed
for data analysis by the research assistants.
To measure the primary outcome of self-efficacy for
self-management, we will survey all participants at baseline
and at 6 months using a structured web-administered
questionnaire [27]. To evaluate the survivor’s knowledge of
their diagnosis, treatment, and related after-effects, survivor
responses to a structured knowledge test [28] will be scored for
accuracy by cross-tabulating with the SCP data obtained in the
baseline survey. To measure the intervention’s impact on the
secondary outcome of treatment-related morbidity, we will
utilize a structured web-administered survey using the REDCap
survey tool [17] at baseline and at 6 months to evaluate the
extent of the intervention’s impact. We will utilize previously
developed instruments that have demonstrated high internal
consistency and validity in prior studies with cancer patients.
Participants will self-report on weight (using participant-owned
scales), fatigue [30], depression [32], anxiety [34], sexual
function [36], distress [37], and sleep quality [38].
Finally, we will utilize mixed methods to assess perceived peer
support among breast cancer survivors. A modification of a
structured scale [29] will be used to measure perceived peer
support at baseline and postintervention to collect quantitative
data. Content analysis [44] will be performed on the online
discussion postings made by the participants on ACESO to
examine survivor conversations for sources of informational,
emotional, and instrumental support by peers. To measure
adherence to posttreatment follow-up, we will ask participants
to self-report the number of any posttreatment clinical visits
made by them at 6 months. We will use their SCP-recommended
follow-up schedule data obtained in the baseline survey to
compute any missed recommended visits and any additional
non-SCP recommended visits made over the last 6 months. We
will collect data on both oncology and primary care visits. The
structure, timing, and sources for each study outcome are
described in Table 1.
Data Analyses
For the first aim, descriptive statistics (means, percentages, and
standard deviations) will be reported for participant
demographics and online user experience (for all 4 subscales:
pragmatic, hedonic, sociability, and usability). To assess
adoption, we will compute the percentage of repeated logins to
ACESO (not including the first-time login during the initial
set-up); we consider ACESO to be adopted among breast cancer
survivors if at least 75% of the users log in at least once after
the first-time login. Participants will be classified as adopters
or nonadopters, and exact logistic regression will be performed
against participant demographics, types of diagnosis, and
treatment types. To analyze qualitative data, audio-recordings
of participant interviews will be transcribed to text and
subsequently coded in NVivo (version 10; QSR International)
for thematic analysis [45]. Thematic analysis will allow for the
identification of patterns or themes within respondents’accounts
of their experiences with ACESO. Inductive coding [46] of the
transcribed recordings will be conducted to allow for the
emergence of dominant and frequent themes highlighting any
barriers and motivators in using ACESO within the respondents’
narratives. We will use multiple coders to strengthen the validity
of the qualitative analysis, who will meet periodically to resolve
any coding disagreements.
For the second aim, we will follow the intention-to-treat
principle and conduct analysis on data obtained from all enrolled
participants, irrespective of the extent of exposure to the
intervention. We will report descriptive statistics and confidence
intervals for each treatment-related morbidity, patient
knowledge, self-efficacy, perceived peer support, and adherence
to follow-up visits. Pre-post changes in our primary and
secondary outcomes will be compared between the intervention
group and the control group using 2-sample t tests, chi-square
tests, and ANCOVA models, controlled by patients’ breast
cancer diagnosis, type of breast cancer treatment, and
demographics. To assess follow-up adherence,
posttreatment-oncologist and primary-care visits will also be
compared between the intervention and the control group using
similar models to compare overuse and underuse of follow-up
visits between the 2 groups. In addition, time series of
observations tracked using ACESO over 6 months (intervention
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group only) will be plotted and analyzed using repeated measure
models for specific change patterns over time.
Results
The study will be conducted over a period of 2 years. Approval
for the study protocol has been obtained from the Institutional
Review Boards of East Carolina University and the University
of Wisconsin-Milwaukee. Upon consultation with breast cancer
oncologists, survivors, and a nurse, we have developed and
refined the online survivorship care plan, ACESO (Figure 1),
and subsequently completed an initial usability assessment to
identify any issues. In prior usability and acceptance evaluations,
survivors indicated high levels of acceptance and interest in the
online survivorship plan [14].
We have also established the ACESO Community Advisory
Board (ACAB), consisting of breast cancer survivors and health
care professionals who will meet biannually and provide
community oversight of the proposed research study. The ACAB
will make recommendations to the research team to ensure that
the study meets its goals in serving the needs of breast cancer
survivors and that our recruitment efforts are inclusive and
representative of the community. In addition, we have created
a National Advisory Committee (NAC) consisting of nationally
recognized scientists and advocates in cancer survivorship who
will monitor the progress of the study and provide guidance and
recommendations to the principal investigators. The NAC will
be updated via progress reports before the commencement and
achievement of all study milestones. The NAC will convene
annually and will be updated on research progress and activities.
Figure 1. ACESO homepage.
Discussion
ACESO is a one-of-a-kind educational and behavioral
intervention that challenges the standard discharge procedure
for survivors and seeks to address several inadequacies found
in conventional SCPs. The standard discharge process entails
a single visit by the survivor after the completion of their initial
breast cancer treatment, where they receive the SCP document
and an explanation of its contents. This approach is flawed in
its assumption of the appropriate timing of the information
delivery by the SCPs. The proposed educational intervention
delivers time-relevant information and reminders to the survivors
at the point of need rather than the point of care; this is
especially pertinent given that not all of the information within
the SCP is relevant or applicable to individual survivors at the
time of discharge, and several treatment-related side effects
occur several weeks or more after completing treatment.
Moreover, the intervention is radical in the presentation of the
content in SCPs. Conventional SCPs include an exhaustive list
of common treatment-related side effects experienced by breast
cancer survivors as well as corresponding recommendations,
which can be overwhelming [47] and may cause a diminished
recall over time [48].
The proposed intervention also transforms the static, paper-based
SCP into a dynamic SCP, allowing continuous access to the
most recent guidelines. As we witness steadily lengthening
lifespans of breast cancer survivors, the SCP must shift from
being an extant guide of recommendations to a living, organic
document that adapts in response to survivors’ changing needs
over time [49]. The proposed intervention's dynamic framework
makes this possible by providing tailored content in response
to survivors’ most current health statuses and care needs. It also
ensures that this content is always consistent with the latest
guidelines, thus providing constant access to an up-to-date SCP.
ACESO also innovates the format of SCPs by transforming the
passive, paper-based SCP into an online, interactive SCP that
allows two-way interaction between the survivor and their SCP.
In contrast to the paper-based SCP, which employs passive
learning based on the reading and retaining of SCP content by
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survivors, the proposed educational intervention employs active
learning to enhance cognition and learning [50].
ACESO incorporates self-regulatory tools and real-time
feedback absent in conventional SCPs, such as self-tracking,
logging and charting of symptoms and quality of life
observations, and tailored alerts (Figure 1). ACESO uses these
alerts to provide survivors with real-time feedback based on
their observations and to identify specific areas of concern. This
combination of self-tracking and real-time feedback has been
shown to improve self-efficacy and reactivity for behavior
change [51]. Similar patient-centered approaches have
previously been shown to improve survivors’ knowledge [52].
Increased levels of self-efficacy and knowledge among survivors
should further result in improved physical and psychosocial
morbidity [53,54]. ACESO also improves upon the generic,
conventional SCP by facilitating personalization and tailoring.
Finally, even though social support, including peer counseling
[55], has been shown to be greatly beneficial in improving
psychosocial distress, conventional SCPs are devoid of any
elements that provide this support to survivors during discharge.
ACESO features a discussion group for survivors to interact
with peers, develop an online community, and offer
informational, emotional, and instrumental peer support, which
should prove to be highly beneficial for survivors as they attempt
to transition into routine life after treatment.
It is also important to note some of the limitations to the study
protocol. Lack of time or interest on the part of prospective
participants will be a potential barrier to recruitment. To ensure
robust recruitment, we will adopt recruitment procedures
previously shown to be successful in our pilot [14] and in other
studies [56,57]. In addition, the recruitment window will last a
full year to allow for adequate recruitment time. Successful
retention of participants for the entire study duration of 6 months
is another concern. In addition to offering all participants an
incentive (eg, a $50 Amazon gift card) to compensate for their
time and effort, we will further split this incentive into 2
installments over the study period (at baseline and 6 months)
to promote continued participation. We also acknowledge the
likelihood of certain eligible participants not having access to
a web-enabled device or the internet. For these participants, we
will provide electronic touchscreen tablets with cellular internet
connectivity to facilitate participation during the entire course
of the study. Certain participants may have limited web literacy
skills to meaningfully utilize the online intervention. All
participants in the intervention group will receive basic training
on how to use ACESO and will be familiarized with its features
and functions. We will also provide all participants with clear,
structured instructions on operating the website. In addition,
the patient navigator will be available for any technical
assistance for all participants via the ACESO website, email,
or phone (during business hours). We also acknowledge that
certain participants will not have access to a weighing scale or
will have varying kinds of weighing scales. To improve the
internal validity of the data and ensure consistency, we will
provide all enrolled and eligible participants with a standard
weighing scale to use when self-reporting weight.
By innovatively combining self-monitoring, personalized
knowledge delivery, and peer support elements into one
comprehensive intervention, the proposed study significantly
improves upon standard discharge procedure by equipping
survivors with tools that provide the long-term support currently
lacking in standard SCPs. Future work should explore the
feasibility of directly incorporating patient-generated health
data using ACESO into health care providers’electronic medical
record.
The study will help toward significantly advancing current
practices in the format, timing, and delivery of SCP content.
We expect that this study will reveal variation in posttreatment
breast cancer survivorship outcomes among the 2 study groups.
Value-laden features within the SCP that allow survivors to
track survivor symptoms and quality of life, as well as
risk-adapted educational alerts, will have a positive impact on
knowledge and self-efficacy for self-management in breast
cancer survivors. The results of this pilot trial will inform the
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